By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mast Therapeutics 

12390 El Camino Real, Suite 150

San Diego  California  92130  U.S.A.
Phone: 858-552-0866 Fax: 858-552-0876


Company News
Mast Therapeutics (MSTX) Announces Possible Adjournment Of Special Stockholders Meeting To Solicit Additional Votes For Merger With Savara 4/20/2017 8:59:57 AM
Mast Therapeutics (MSTX) Reminds Stockholders To Vote For The Proposed Merger With Savara 4/17/2017 6:35:43 AM
Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Mast Therapeutics (MSTX) Stockholders Vote "FOR" The Proposed Merger And Related Proposals 4/11/2017 7:56:54 AM
Mast Therapeutics (MSTX) And Savara Announce Approval To List Common Stock On The Nasdaq Capital Market 4/10/2017 6:43:35 AM
Mast Therapeutics (MSTX) Sets Date For Special Meeting Of Stockholders To Vote On Proposed Merger With Savara 3/16/2017 10:53:35 AM
Mast Therapeutics (MSTX) Reports Fourth Quarter And Full Year 2016 Financial Results 3/7/2017 10:35:56 AM
Mast Therapeutics (MSTX) Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis Patients 3/6/2017 6:22:31 AM
Mast Therapeutics (MSTX) And Savara Sign Merger Agreement 1/9/2017 7:06:35 AM
Mast Therapeutics (MSTX) Announces Initiation Of Patient Enrollment In Additional Phase 2 Study Of AIR001 For The Treatment Of Heart Failure With Preserved Ejection Fraction 12/6/2016 7:23:46 AM
Pharma Bro Warned You: Mast Therapeutics (MSTX) Evaluating Strategic Options, Receives Interest From Private Buyers 11/21/2016 6:27:12 AM